TS Pharm

TS Pharm Co., Ltd., founded in 1993 and headquartered in Seoul, South Korea, is a specialized pharmaceutical company focused on the development, manufacturing, and distribution of a wide range of prescription (ETC) and over-the-counter (OTC) medications. The company is primarily recognized for its strong portfolio in gastroenterology, neurology, and cardiology, featuring key products such as TS-Lansoprazole and TS-Donepezil. TS Pharm operates a GMP-certified manufacturing facility in Hwaseong, which produces various dosage forms including oral solids and liquids. A key pillar of its business strategy is the development of incrementally modified drugs (IMDs) and high-quality generic formulations utilizing advanced drug delivery technologies. Through its dedicated R&D center, the company focuses on formulation optimization to improve therapeutic efficacy and patient adherence. TS Pharm maintains a robust presence in the domestic Korean market while actively exploring global expansion through exports and strategic international partnerships.